NPI: 1477122638 · LONGWOOD, FL 32750 · Pediatrics Physician · NPI assigned 06/22/2021
Authorized official BRIDGES, ROBERT controls 18+ related entities in our dataset. Read more
| Authorized Official | BRIDGES, ROBERT (EVP, OPERATIONS) |
| Parent Organization | CHILDREN'S HEALTH ALLIANCE, LLC |
| NPI Enumeration Date | 06/22/2021 |
Other providers sharing the same authorized official: BRIDGES, ROBERT
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 1,376 | $95K |
| 2022 | 7,527 | $522K |
| 2023 | 413 | $33K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,712 | 1,585 | $202K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1,930 | 1,787 | $148K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 617 | 613 | $67K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 443 | 442 | $55K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 489 | 479 | $54K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1,162 | 1,152 | $51K |
| 90461 | 486 | 481 | $18K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 142 | 139 | $16K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 134 | 129 | $11K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 148 | 146 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 88 | 84 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 118 | 115 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 132 | 132 | $3K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 107 | 106 | $1K |
| 99188 | 29 | 29 | $638.08 | |
| 96127 | 125 | 119 | $435.22 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 23 | 23 | $402.30 |
| 90670 | 64 | 64 | $271.00 | |
| 83655 | 24 | 24 | $236.16 | |
| 90710 | 38 | 38 | $236.03 | |
| 90686 | 498 | 496 | $203.69 | |
| 85018 | 95 | 93 | $153.83 | |
| 87807 | 12 | 12 | $141.70 | |
| 92551 | 112 | 105 | $39.00 | |
| 81003 | 15 | 12 | $36.52 | |
| 99177 | 75 | 72 | $31.50 | |
| 36416 | 192 | 183 | $18.00 | |
| 90633 | 26 | 26 | $0.00 | |
| 90734 | 50 | 50 | $0.00 | |
| 99173 | 32 | 29 | $0.00 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 62 | 54 | $0.00 |
| 90651 | 95 | 95 | $0.00 | |
| 90696 | 12 | 12 | $0.00 | |
| 90647 | 13 | 13 | $0.00 | |
| 90620 | 16 | 16 | $0.00 |